These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7576748)

  • 1. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
    Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
    Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.
    Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
    Gynecol Oncol; 1996 Aug; 62(2):254-9. PubMed ID: 8751558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
    Chou FF; Eng HL; Sheen-Chen SM
    Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
    Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
    Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential.
    Peters WA; Howard DR; Andersen WA; Figge DC
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1646-53; discussion 1653-4. PubMed ID: 1615971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation, ploidy and prognosis in uterine smooth muscle tumours.
    Jeffers MD; Oakes SJ; Richmond JA; Macaulay EM
    Histopathology; 1996 Sep; 29(3):217-23. PubMed ID: 8884349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of prognostic factors in uterine carcinosarcoma.
    Nordal RR; Kristensen GB; Stenwig AE; Nesland JM; Pettersen EO; Trope CG
    Gynecol Oncol; 1997 Dec; 67(3):316-21. PubMed ID: 9441781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
    Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
    Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry.
    Tsushima K; Stanhope CR; Gaffey TA; Lieber MM
    Mayo Clin Proc; 1988 Mar; 63(3):248-55. PubMed ID: 3343869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
    Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy in endometrial carcinoma: major objective prognostic factor.
    Britton LC; Wilson TO; Gaffey TA; Cha SS; Wieand HS; Podratz KC
    Mayo Clin Proc; 1990 May; 65(5):643-50. PubMed ID: 2348728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leiomyosarcomas and benign smooth muscle tumors of the stomach: nuclear DNA patterns studied by flow cytometry.
    Tsushima K; Rainwater LM; Goellner JR; van Heerden JA; Lieber MM
    Mayo Clin Proc; 1987 Apr; 62(4):275-80. PubMed ID: 3561042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
    Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
    Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology.
    Layfield LJ; Liu K; Dodge R; Barsky SH
    Arch Pathol Lab Med; 2000 Feb; 124(2):221-7. PubMed ID: 10656730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of DNA ploidy in primary gastric leiomyosarcoma.
    Suzuki H; Sugihira N
    Br J Surg; 1993 Dec; 80(12):1549-50. PubMed ID: 8298922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.